Literature DB >> 20726877

An exploratory randomized controlled trial of immediate versus delayed withdrawal of antiepileptic drugs in patients with psychogenic nonepileptic attacks (PNEAs).

Maria Oto1, Colin A Espie, Roderick Duncan.   

Abstract

PURPOSE: To determine whether withdrawal of antiepileptic drugs (AEDs) in patients with psychogenic nonepileptic attacks (PNEAs) improves outcome.
METHODS: Randomized controlled trial of AED withdrawal in patients with PNEAs. Patients were randomized to immediate or delayed (9 months) withdrawal of AEDs. We recorded spell frequency, changes in work status, use of emergency medical services, and psychological status at baseline, 9 months, and 18 months.
RESULTS: Of 193 patients screened, 38 fulfilled entry criteria, 13 declined participation, and 25 were randomized. Fourteen patients were randomized to immediate withdrawal (IW) and 11 patients to delayed withdrawal (DW). There was a significant reduction in spell frequency from baseline to 9 months in the IW group but not in the DW group (p = 0.028). There was a significantly greater reduction in use of rescue medication in the IW group compared to the DW group between baseline and 9 months (p = 0.002). Emergency health care utilization dropped to zero in both groups by the end of the study. Psychological measures reflecting internal locus of control increased significantly more in the IW group (p = 0.005). DISCUSSION: Stringent diagnostic criteria and an increasing tendency for patients to be referred before AED prescription limited the recruitment and the power of the study. Our data nonetheless provide evidence that some outcomes are improved by AED withdrawal in patients with PNEAs. Wiley Periodicals, Inc.
© 2010 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726877     DOI: 10.1111/j.1528-1167.2010.02696.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Treatment of functional (psychogenic) movement disorders.

Authors:  Luciana Ricciardi; Mark J Edwards
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  Differentiating between nonepileptic and epileptic seizures.

Authors:  Orrin Devinsky; Deana Gazzola; W Curt LaFrance
Journal:  Nat Rev Neurol       Date:  2011-03-08       Impact factor: 42.937

Review 3.  Treatment of Psychogenic Nonepileptic Seizures.

Authors:  M Raquel Lopez; W Curt LaFrance
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-08       Impact factor: 6.030

Review 4.  Nonepileptic seizures: an updated review.

Authors:  David L Perez; W Curt LaFrance
Journal:  CNS Spectr       Date:  2016-03-21       Impact factor: 3.790

Review 5.  Recent developments in our understanding of the semiology and treatment of psychogenic nonepileptic seizures.

Authors:  Laura H Goldstein; John D C Mellers
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

6.  Psychogenic nonepileptic seizures; beyond differentiating from epileptic seizures.

Authors:  Sang Ook Nam
Journal:  Clin Exp Pediatr       Date:  2020-11-12

7.  Outcome measurement in functional neurological disorder: a systematic review and recommendations.

Authors:  Susannah Pick; David G Anderson; Ali A Asadi-Pooya; Selma Aybek; Gaston Baslet; Bastiaan R Bloem; Abigail Bradley-Westguard; Richard J Brown; Alan J Carson; Trudie Chalder; Maria Damianova; Anthony S David; Mark J Edwards; Steven A Epstein; Alberto J Espay; Béatrice Garcin; Laura H Goldstein; Mark Hallett; Joseph Jankovic; Eileen M Joyce; Richard A Kanaan; Roxanne C Keynejad; Kasia Kozlowska; Kathrin LaFaver; W Curt LaFrance; Anthony E Lang; Alex Lehn; Sarah Lidstone; Carine W Maurer; Bridget Mildon; Francesca Morgante; Lorna Myers; Clare Nicholson; Glenn Nielsen; David L Perez; Stoyan Popkirov; Markus Reuber; Karen S Rommelfanger; Petra Schwingenshuh; Tereza Serranova; Paul Shotbolt; Glenn T Stebbins; Jon Stone; Marina Aj Tijssen; Michele Tinazzi; Timothy R Nicholson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-02-28       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.